Form 4: AMN Healthcare Executive Reports Stock Transactions Following Vesting of Performance-Based Stock Units
SEC Form 4 Filing
Mark Christopher Hagan, Chief Information and Digital Officer of AMN Healthcare Services Inc., reports acquisition and disposal of common stock related to vested performance-based stock units.
Summary
- On February 21, 2025, Mark Christopher Hagan, Chief Information and Digital Officer of AMN Healthcare Services Inc., reported transactions involving AMN common stock.
- These transactions include the acquisition of 2,664 shares of common stock due to the vesting of Performance Restricted Stock Units (PRSUs) granted on January 15, 2022.
- The vesting of these PRSUs was contingent upon AMN Healthcare achieving specific adjusted EBITDA targets over a three-year period from January 1, 2022, to December 31, 2024, with 66% of the target amount being earned.
- Additionally, 954 shares were disposed of at a price of $25.84 per share to cover tax obligations.
- Following these transactions, Hagan directly owns 32,708 shares of AMN Healthcare common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive following the vesting of performance-based stock units. The vesting itself suggests the company met some performance targets, which is mildly positive.
Positives
- The vesting of PRSUs indicates that AMN Healthcare achieved a significant portion (66%) of its performance targets related to adjusted EBITDA over the specified three-year period.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests between management and shareholders.
Stakeholder Impact
- The stock transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| January 15, 2022 | Date the Performance Restricted Stock Unit (PRSU) award was granted by the Company. |
| January 1, 2022 | Start date of the three-year performance period for the PRSU award. |
| December 31, 2024 | End date of the three-year performance period for the PRSU award. |
| February 21, 2025 | Date of the stock acquisition and disposal transactions. |
| February 24, 2025 | Date of signature for the Form 4 filing. |
Keywords
AMN Healthcare, Mark Christopher Hagan, Form 4, Stock Transaction, Performance Restricted Stock Units, PRSU, Adjusted EBITDA, Vesting, Common Stock, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.